Mendelian inheritance of artificial chromosomes - synthetic mammalian artificial chromosomes (macs) represent a new frontier in genome technology, with the potential to transform chromosome and…
Active Project Grant Awarded Last action
- Award ID
- R01HG012445
- Recipient
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,488,990
Award facts
- Assistance listing
- 93.310 Trans-NIH Research Support
- Completion date 88% complete
- Originally
- Funding
-
- $9,331,916.00 Federal
- $1,157,074.00 Non-federal
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from USAspending.gov.
Description
Mendelian inheritance of artificial chromosomes - synthetic mammalian artificial chromosomes (macs) represent a new frontier in genome technology, with the potential to transform chromosome and synthetic biology and stimulate the development of numerous radical advances in medicine. Human genome project-write aims to generate an entire set of synthetic human chromosomes. Short of this ambitious goal, macs have enormous potential for breakthroughs in biotechnology and medicine, such as creating humanized animal models for drug development or for harvesting patient- personalized organs for transplantation. Furthermore, building macs from minimal components will advance our fundamental understanding of what comprises a mammalian chromosome. As vehicles for genetic inheritance, fully functional chromosomes are faithfully transmitted through mitosis and the specialized meiotic divisions underlying eukaryotic sexual reproduction and mendelian inheritance. Our goal is to construct the first macs that achieve faithful inheritance through the germline, using mouse as a model system. One obstacle is the centromere, the locus on each chromosome that directs transmission through both mitosis and meiosis. Because mammalian centromeres are not encoded in the DNA sequence, IT is unclear how to build synthetic chromosomes containing this crucial element. There are additional challenges to create macs that pair and recombine as homologous chromosomes in meiosis. To solve these problems, we will hijack the existing cellular machinery for assembling centromere chromatin and incorporate additional genetic elements to ensure meiotic pairing and recombination. This effort requires innovation at multiple levels: designing MAC vectors encoding key functional elements, assembling large synthetic DNA constructs, and ultimately creating animals to test macs in vivo. The proposed work builds on recent advances from the CO-investigators' teams in all of these areas, and we have key tools and expertise in place to build the necessary DNA templates, introduce them into embryos, analyze the outcomes, and develop alternative strategies as necessary. The most meaningful preliminary data would be to show a synthetic artificial chromosome that is successfully transmitted through mitosis and meiosis in vivo, but achieving this step is a major goal of our proposal and will require substantial investment of time and effort. Thus, we are requesting support for this project without the preliminary data that would demonstrate high likelihood of success, justifying consideration of our proposal as part of the t-R01 mechanism. We use mouse as a relatively rapid and tractable mammalian model system with outstanding opportunities for testing and debugging macs, and our advances should readily transfer to other species for applications in biotechnology and medicine. Success in this project will represent a quantum leap in the development of synthetic artificial chromosome that are fully functional in vivo, providing unprecedented genome engineering capabilities in animal models and enabling diverse synthetic biology applications.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,169,628 | $0 | |
| Amendment | $1,157,074 | $0 | |
| Original award | $1,157,074 | $1,157,074 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| J. Craig Venter Institute, Inc. | $469,705 | |
| J. Craig Venter Institute, Inc. | $219,196 | |
| J. Craig Venter Institute, Inc. | $313,137 |
Quick answers
Who received award R01HG012445?
R01HG012445 was awarded to The Trustees Of The University Of Pennsylvania by National Human Genome Research Institute (National Institutes of Health) on September 10, 2021.
How much is award R01HG012445 worth?
$10,488,990 has been obligated on R01HG012445: $9,331,916 in federal funding and $1,157,074 in non-federal funding.
Which agency awarded R01HG012445?
National Human Genome Research Institute (National Institutes of Health) awarded R01HG012445, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award